| Mepha Pharma AG - Mirtazap-Mepha 45, Filmtabletten | | 61333 | | 03 | | Mirtazap-Mepha 45 | | Filmtabletten | | N06AX11 | | Mirtazapine | | 06.06.2011 | | |
| | Composition | | Filmtablette: mirtazapinum 45 mg, lactosum monohydricum 339.99 mg, maydis amylum, povidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, macrogolum 6000, E 171 pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose | additional_information |
|---|
| Mirtazapine | 45 mg | Filmtablette |
| | | | Inactive agents | Dose | additional_information |
|---|
| E 171 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 339.99 mg | | | Macrogol | 6000 | | | Magnesii Stearas | | | | Maydis Amylum | | | | Povidone | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 009 | 30 Tablet(s) | 25.62 | 45.80 | B | | Yes | | 010 | 100 Tablet(s) | 72.63 | 99.80 | B | | Yes |
|
|
